Opinion: I studied Reddit forums on menopause — and found what doctors are missing

In forums on Reddit, women share tales of having perimenopause and menopause symptoms misdiagnosed or dismissed as mental health disorders, early-onset dementia, or autoimmune issues, resulting in months or years of unnecessary testing. They discuss sudden mood shifts of rage, and panic, and how they are routinely labeled by their doctor as primary psychiatric conditions rather than hormonal fluctuations, leading to unnecessary antidepressant prescriptions. Severe brain fog, memory lapses, and sleeplessness from night sweats — all common signs of menopause or perimenopause — often terrify women into believing they have a degenerative cognitive disease before considering that these seemingly disconnected symptoms might be related to perimenopause or menopause. These conversations are not just chatter — they are scientifically important. Because they are not responding to a questionnaire written by a researcher, they might be able to offer important clues. What might medicine be missing if it isn’t listening? In a study my colleagues and I published recently in JAMA Network Open, we compared menopause-related discussions from one of the world’s largest online menopause communities on Reddit with more than 2 million electronic health record notes at the University of California, San Francisco. Clinical records focused largely on physical symptoms. Online, women discussed emotional well-being nearly three times as often as they appeared in clinical records. Cognitive symptoms, brain fog, memory problems, and difficulty finding words appear online nearly four times as often. In other words, some of the symptoms women were talking about most online were among the symptoms least represented in the clinical records. This gap does not exist in a vacuum. There is a long history of women’s pain and symptoms being underestimated, psychologized, or dismissed in medicine. In online menopause discussions, women describe cognitive and emotional symptoms being ignored, trivialized, or even laughed off by doctors. That may help explain why these symptoms are so much less visible in electronic health records. If a woman’s brain fog is recorded as early signs of dementia, her anxiety as psychiatric condition, or her sleeplessness as an isolated complaint, the symptom or misdiagnosis may enter the medical record, but its connection to menopause disappears. And after being repeatedly discounted, some women may stop bringing up these symptoms at all. Either way, the menopause record becomes incomplete. Women learn that certain symptoms don’t “count,” clinicians don’t document them as menopause, and researchers don’t see them in the data. The next generation of studies, guidelines, and drug trials is then built on a record that never captured the full experience in the first place. That is how symptoms become silent — and how they can stay silent for generations. The symptoms women are discussing online should become the questions researchers ask next. Instead of disregarding cognitive and mood changes as unrelated complaints, we need to study when and how they are connected to menopause and make sure clinicians know to ask about them. I have seen this same pattern across my research: When medicine doesn’t have the answers or patients feel medicine isn’t listening, they turn to one another online, searching for people who share their experiences and answers they haven’t found elsewhere. A clinical record captures what happened in an appointment. Conversation in an online forum captures what a person is actually living through. This is medicine’s blind spot: what isn’t documented often isn’t recorded. What isn’t recorded isn’t studied. And what isn’t studied doesn’t become better care. Twenty or 30 years ago, how often did a hospital questionnaire ask about sexual orientation or gender identity? Even today, would every patient feel comfortable telling a health care system who they love, their sexual practices, or how they identify, particularly if they have experienced discrimination or fear that disclosure could affect their care? Some of my earliest research asked whether unsolicited online conversations could tell us something about LGBTQ+ experiences in health care that traditional measures were missing. We found that social media discussions could reveal differences in hospital experiences and health care inequities. The same idea applies to rare, stigmatized, and poorly understood conditions. Medicine teaches clinicians that when they hear hoofbeats, they should think horses, not zebras. But zebras still exist. For people with rare conditions like interstitial cystitis/bladder pain syndrome, a chronic and difficult-to-treat pain condition, patients turned to one another online to discuss what treatments worked and what didn’t, side effects, long-term risks, and alternatives, often searching for answers they felt they weren’t getting from their doctors or simply couldn’t find in the medical literature. We need richer data, not simply more data. Listening responsibly to patient conversations can reveal discrimination we did not measure, treatment experiences we did not ask about, and symptoms we did not know we were missing. This matters particularly now because menopause is finally having a moment. Melinda French Gates has pledged more than $600 million to women’s health over the past two years, with $215 million of that earmarked for midlife and menopause care and training. Actresses, athletes, and executives are discussing hot flashes and vaginal dryness as openly as they once discussed their skincare routines. This is progress, and I don’t want to undersell it. But we must make sure the menopause boom becomes more than another opportunity to sell treatments and products to women. The increased attention to menopause also gives us an opportunity to understand which symptoms are truly connected to the menopausal transition and which may have other explanations. Online conversations tell us what women are experiencing; clinical records tell us what medicine is documenting. By comparing the two, we can find the gaps and turn those gaps into questions science can test. That is why listening to women online matters. These conversations are not medical truth, but neither is the absence of a symptom from a medical record proof that it does not exist. The opportunity is to bring these sources together, listen to what women are experiencing, and investigate what medicine may be missing. So before we build the next menopause drug, app, wearable, or clinical guideline, we need to understand what women are actually experiencing. That means looking in places medicine has not traditionally looked. Millions of women are already describing their health online, in their own words, without a researcher deciding which questions they are allowed to answer or a checklist deciding which symptoms count. These conversations can show us where to look next and what questions to ask when a woman walks into the clinic. But listening online is only half the solution. We also need to listen differently in the exam room. Clinicians need to ask broader questions: What else has changed? What are you experiencing that you don’t understand? What feels different from a year ago? And when a woman describes something that doesn’t fit what we already know, doctors’ first response should not be to dismiss it because it isn’t in the textbook. We should ask whether the textbook is incomplete. Yulin Hswen is an associate professor of epidemiology and biostatistics in the Artificial Intelligence Interdisciplinary Institute at the University of Maryland, where she studies how AI and online conversations can help medicine see what it has been missing.